NCT07145047View on ClinicalTrials.gov

Clinical Study of Oncolytic Virus in Glioblastoma

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Glioblastoma (GBM)

Interventions

BIOLOGICAL

oncolytic virus

Intratumoral injection of oncolytic virus.

Trial Locations (1)

621000

RECRUITING

Mianyang Central Hospital, Mianyang

All Listed Sponsors

lead

Mianyang Central Hospital

OTHER